GlassScriptPhysician profile
Darla K Granger
NPI 1700999083
$3,273.40
in general payments reported to CMS, 2019-2025
14 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,152 · 2020: $156 · 2023: $231 · 2024: $291 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $1,750.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $275.24 | 2019 | |
| Medtronic, INC. | $169.89 | 2025 | Interstim |
| Tela Bio, INC. | $148.66 | 2024 | Ovitex 2s |
| Acera Surgical, INC. | $147.64 | 2025 | Restrata Wound Matrix |
| Sanofi-Aventis U.S. LLC | $142.38 | 2024 | |
| Gilead Sciences, INC. | $128.31 | 2019-2020 | |
| Vifor Pharma, INC. | $118.30 | 2023 | Veltassa |
| Takeda Pharmaceuticals U.S.A., INC. | $112.70 | 2023 | Livtencity |
| Alexion Pharmaceuticals, INC. | $107.10 | 2025 | Ultomiris |
| Philips North America LLC | $71.43 | 2020 | |
| Medtronic Vascular, INC. | $70.00 | 2020 | |
| Merck Sharp & Dohme LLC | $17.95 | 2025 | Prevymis |
| Biomerieux INC | $13.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darla Granger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.